Bisogno G, Ferrari A, Bien E, Brecht I B, Brennan B, Cecchetto G, Godzinski J, Orbach D, Reguerre Y, Stachowicz-Stencel T, Schneider D T
Clinic of Pediatric Oncology, University of Padova, Padova, Italy.
Klin Padiatr. 2012 Oct;224(6):416-20. doi: 10.1055/s-0032-1327608. Epub 2012 Nov 9.
The low incidence and the heterogeneity of very rare tumors (VRTs) demand for international cooperation. In 2008, EXPeRT (European Cooperative Study Group for Pediatric Rare Tumors) was founded by national groups from Italy, France, United Kingdom, Poland and Germany. The first aims of EXPeRT were to agree on a uniform definition of VRTs and to develop the currently most relevant scientific questions. Current initiatives include international data exchange, retrospective and prospective studies of specific entities, and the development of harmonized and internationally recognized guidelines. Moreover, EXPeRT established a network for expert consultation to assist in clinical decision in VRTs.
极罕见肿瘤(VRTs)的低发病率和异质性需要国际合作。2008年,EXPeRT(欧洲儿科罕见肿瘤合作研究组)由来自意大利、法国、英国、波兰和德国的国家小组共同创立。EXPeRT的首要目标是就VRTs的统一定义达成一致,并提出当前最相关的科学问题。当前的举措包括国际数据交换、特定实体的回顾性和前瞻性研究,以及制定统一且国际认可的指南。此外,EXPeRT建立了一个专家咨询网络,以协助VRTs的临床决策。